At a recent press conference at Mar-a-Lago, President-elect Donald Trump made a bold promise to take on the powerful Pharmacy Benefit Managers (PBMs) responsible for inflating prescription drug prices in the U.S. Trump criticized PBMs, calling them a “horrible middleman” that profits by driving up drug costs without adding value. He vowed to eliminate the middleman and reduce drug prices to levels “that nobody has ever seen before.”
Healthcare spending in the United States surged by 7.5% to $4.9 trillion in 2023, driven by increased medical service use and rising enrollment in private health plans, according to a report from the Centers for Medicare and Medicaid Services (CMS).
The U.S. government has agreed to pay nearly $116 million to settle lawsuits brought by over 100 women who suffered sexual abuse and mistreatment at the now-closed Federal Correctional Institution (FCI) in Dublin, California.
President Joe Biden’s decision to grant clemency to nearly 1,500 individuals has sparked controversy, with critics questioning the inclusion of individuals convicted of serious offenses.
Texas Attorney General Ken Paxton has filed a groundbreaking lawsuit against Dr. Margaret Daley Carpenter, a New York physician, for prescribing abortion pills to a Texas woman who suffered severe complications, including heavy bleeding, landing her in the emergency room.
Authorities in West Tennessee have seized hundreds of vials of black-market weight-loss drugs during a series of searches at a residence and two clinics, following a two-month investigation.
The Brazilian Chamber of Deputies has passed a controversial bill that includes provisions for the chemical castration of individuals convicted of pedophilia.
House Speaker Mike Johnson (R-LA) is preparing to unveil a government spending bill that could include key components of President-elect Donald Trump’s healthcare agenda. Among the priorities under consideration is reforming Pharmacy Benefit Manager (PBM) practices, a move aimed at lowering prescription drug costs for seniors by tackling middleman-driven price inflation.
